DE3262998D1 - Mb-530b derivatives, their preparation and pharmaceutical compositions containing them - Google Patents

Mb-530b derivatives, their preparation and pharmaceutical compositions containing them

Info

Publication number
DE3262998D1
DE3262998D1 DE8282304507T DE3262998T DE3262998D1 DE 3262998 D1 DE3262998 D1 DE 3262998D1 DE 8282304507 T DE8282304507 T DE 8282304507T DE 3262998 T DE3262998 T DE 3262998T DE 3262998 D1 DE3262998 D1 DE 3262998D1
Authority
DE
Germany
Prior art keywords
group
chem
ester
compounds
lactone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282304507T
Other languages
English (en)
Inventor
Akira Fermentation Re Terahara
Minoru Analytical And M Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of DE3262998D1 publication Critical patent/DE3262998D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8282304507T 1981-08-27 1982-08-26 Mb-530b derivatives, their preparation and pharmaceutical compositions containing them Expired DE3262998D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56134558A JPS5835144A (ja) 1981-08-27 1981-08-27 Mb−530b誘導体およびその製造法

Publications (1)

Publication Number Publication Date
DE3262998D1 true DE3262998D1 (en) 1985-05-15

Family

ID=15131129

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282304507T Expired DE3262998D1 (en) 1981-08-27 1982-08-26 Mb-530b derivatives, their preparation and pharmaceutical compositions containing them

Country Status (7)

Country Link
US (2) US4517373A (de)
EP (1) EP0074222B1 (de)
JP (1) JPS5835144A (de)
AT (1) ATE12638T1 (de)
CA (1) CA1197484A (de)
DE (1) DE3262998D1 (de)
IE (1) IE53740B1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5855443A (ja) * 1981-09-25 1983-04-01 Sankyo Co Ltd オクタヒドロナフタリン誘導体およびその製造法
US4472426A (en) * 1982-12-22 1984-09-18 Merck & Co., Inc. Antihypercholesterolemic compounds
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
EP0245990A3 (de) * 1986-05-05 1989-07-19 Merck & Co. Inc. Antihypercholesterolemische Verbindungen
US4864038A (en) * 1986-05-05 1989-09-05 Merck & Co., Inc. Antihypercholesterolemic compounds
US4771071A (en) * 1986-05-05 1988-09-13 Merck & Co., Inc. Antihypercholesterolemic compounds
US4766145A (en) * 1986-05-05 1988-08-23 Merck & Co., Inc. Antihypercholesterolemic compounds
US4847306A (en) * 1986-05-05 1989-07-11 Merck & Co., Inc. Antihypercholesterolemic compounds
US4661483A (en) * 1986-05-05 1987-04-28 Merck & Co., Inc. Antihypercholesterolemic lactone compounds, compositions and use
EP0245004A3 (de) * 1986-05-05 1989-07-26 Merck & Co. Inc. Antihypercholesterolemische Verbindungen
EP0245003A3 (de) * 1986-05-05 1989-07-19 Merck & Co. Inc. Antihypercholesterolemische Verbindungen
USRE36481E (en) * 1986-06-23 2000-01-04 Merck & Co., Inc. HMG-CoA reductase inhibitors
US4940727A (en) * 1986-06-23 1990-07-10 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors
US5116870A (en) * 1986-06-23 1992-05-26 Merck & Co., Inc. HMG-CoA reductase inhibitors
US4678806A (en) * 1986-09-02 1987-07-07 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
US4736064A (en) * 1986-09-29 1988-04-05 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
US4833258A (en) * 1987-02-17 1989-05-23 Merck & Co., Inc. Intermediates useful in the preparation of HMG-COA reductase inhibitors
US4719229A (en) * 1987-05-13 1988-01-12 Merck & Co., Inc. Antihypercholesterolemic agents
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
EP0306263B1 (de) * 1987-09-02 1992-03-18 Merck & Co. Inc. Inhibitoren von HMG-CoA-Reduktase
US4857547A (en) * 1988-01-07 1989-08-15 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
EP0331250B1 (de) * 1988-03-02 1994-04-13 Merck & Co. Inc. Antihypercholesterolemisches Mittel
US5021453A (en) * 1988-03-02 1991-06-04 Merck & Co., Inc. 3-keto HMG-CoA reductase inhibitors
US4997755A (en) * 1988-04-15 1991-03-05 Merck & Co., Inc. HMG-CoA reductase inhibitors produced by Nocardia sp. (MA 6455)
EP0337548A3 (de) * 1988-04-15 1991-08-14 Merck & Co. Inc. Inhibitoren von HMG-COA-Reduktase, hergestellt durch Nocardia SP.(MA6455)(ATCC 53695)
US4963538A (en) * 1988-06-29 1990-10-16 Merck & Co., Inc. 5-oxygenated HMG-CoA reductase inhibitors
EP0381478A1 (de) * 1989-02-01 1990-08-08 Merck & Co. Inc. Verfahren zur Herstellung von 6-alpha-Hydroxymethyl-Lovastatin-Derivaten
US5041562A (en) * 1989-06-09 1991-08-20 Merck & Co., Inc. 3-keto HMG-CoA reductase inhibitors
US5010105A (en) * 1989-06-09 1991-04-23 Merck & Co., Inc. Antihypercholesterolemic compounds
US5001241A (en) * 1989-06-09 1991-03-19 Merck & Co., Inc. 3-KETO HMG-CoA reductase inhibitors
US4937259A (en) * 1989-06-09 1990-06-26 Merck & Co., Inc. Antihypercholesterolemic compounds
DE69025817T2 (de) * 1989-06-09 1996-11-14 Merck & Co Inc 3-Keto-HMG-CoA Reduktase-Inhibitoren
US4965200A (en) * 1989-06-23 1990-10-23 Merck & Co., Inc. Process for the preparation of 3-keto, 5-hydroxy simvastatin analogs
US4997849A (en) * 1989-06-23 1991-03-05 Merck & Co., Inc. Microbial transformation of simvastatin
US5112857A (en) * 1990-09-04 1992-05-12 Merck & Co., Inc. Hmg-coa reductase inhibitor metabolites
FR2709126B1 (fr) * 1993-08-18 1995-09-29 Adir Nouveaux dérivés de naphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (de) * 1974-06-07 1981-03-18
JPS5925599B2 (ja) * 1979-02-20 1984-06-19 三共株式会社 新生理活性物質モナコリンkおよびその製造法
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
AU535944B2 (en) * 1979-06-15 1984-04-12 Merck & Co., Inc. Hypocholestermic fermentation products from aspergillus
JPS56150037A (en) * 1980-04-22 1981-11-20 Sankyo Co Ltd Hydronaphthalene compound
MX7065E (es) * 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
US4450171A (en) * 1980-08-05 1984-05-22 Merck & Co., Inc. Antihypercholesterolemic compounds
JPS57185276A (en) * 1981-05-11 1982-11-15 Sankyo Co Ltd Dihydro-dum-4 and dihydro-isodum-4 and their derivative
US4499289A (en) * 1982-12-03 1985-02-12 G. D. Searle & Co. Octahydronapthalenes

Also Published As

Publication number Publication date
EP0074222A1 (de) 1983-03-16
JPS5835144A (ja) 1983-03-01
JPH0371419B2 (de) 1991-11-13
US4517373A (en) 1985-05-14
CA1197484A (en) 1985-12-03
IE53740B1 (en) 1989-02-01
EP0074222B1 (de) 1985-04-10
IE822061L (en) 1983-02-27
US4820865A (en) 1989-04-11
ATE12638T1 (de) 1985-04-15

Similar Documents

Publication Publication Date Title
DE3262998D1 (en) Mb-530b derivatives, their preparation and pharmaceutical compositions containing them
SE8103560L (sv) Ml-236b-derivat och framstellning derav
SE8206580L (sv) Framstellning av 3-hydroxi-ml-236b-derivat
KR940014294A (ko) 헥사히드로나프탈렌 에스테르 유도체, 그의 제조방법 및 그의 치료적 용도
IE861127L (en) Condensed oxygen heterocyclics
NO176147C (no) Fremgangsmåte for fremstilling av et additivkonsentrat egnet for inkorporering i smöreolje
EP0215665A3 (en) Hydroxy-ml-236b derivatives, their preparation and use
AU547968B2 (en) Ml-236b derivatives i.e. alactone and the corresponding free hydroxy-carboxylic acid
ENDO et al. Microbial phosphorylation of compactin (ML-236B) and related compounds
AU4318293A (en) A process for the preparation of s-(+)-2-(3-benzoylphenyl)propionic acid by enzyme-catalysed enantioselective transesterification in an organic solvent
KR930023333A (ko) 콜레스테롤 생합성 억제를 위한 옥타히드로나프탈렌 옥심 유도체, 및 그의 제법 및 용도
KR890003955A (ko) 광학 활성 인-함유 작용성 아세트산 유도체의 효소적 제조방밥
JPS57171959A (en) Polyprenylsulfone derivative and its preparation
JPS5750894A (en) Preparation of ml-236b derivative
SE8803143L (sv) Alternativa energisubstrat
JPS55118428A (en) Biochemical resolution
KR830006427A (ko) Ml-236b 유도체의 제조방법
TH219A (th) กรรมวิธีในการเตรียมอนุพันธ์ของ ควิโนลีนคาร์บอก-ซิลิค แอซิด
KR900006314A (ko) 4-옥소퀴놀린 카복실산 유도체의 제조방법
KR920019717A (ko) 고순도 메틸-3-(3,5- 디-tert- 부틸-4- 히드록시페닐)프로피오네이트의 제조방법

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Free format text: STREHL, P., DIPL.-ING. DIPL.-WIRTSCH.-ING. SCHUEBEL-HOPF, U., DIPL.-CHEM. DR.RER.NAT., PAT.-ANWAELTE, 8000 MUENCHEN